Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 2
2009 7
2010 7
2011 7
2012 9
2013 5
2014 5
2015 13
2016 8
2017 4
2018 5
2019 11
2020 7
2021 10
2022 11
2023 11
2024 5
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Ehrhardt MJ, Leerink JM, Mulder RL, Mavinkurve-Groothuis A, Kok W, Nohria A, Nathan PC, Merkx R, de Baat E, Asogwa OA, Skinner R, Wallace H, Lieke Feijen EAM, de Ville de Goyet M, Prasad M, Bárdi E, Pavasovic V, van der Pal H, Fresneau B, Demoor-Goldschmidt C, Hennewig U, Steinberger J, Plummer C, Chen MH, Teske AJ, Haddy N, van Dalen EC, Constine LS, Chow EJ, Levitt G, Hudson MM, Kremer LCM, Armenian SH. Ehrhardt MJ, et al. Among authors: van dalen ec. Lancet Oncol. 2023 Mar;24(3):e108-e120. doi: 10.1016/S1470-2045(23)00012-8. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052966
Risk Factors for Valvulopathy Among Childhood Cancer Survivors.
Aho Glele R, Feijen EAM, Fresneau B, Reulen RC, Allodji RS, Vu-Bezin G, Schwartz B, Journy N, Minard-Colin V, Bagnasco F, Bardi E, Belle FN, Byrne J, van Dalen EC, Teepen JC, Grabow D, Kaatsch P, Hjorth L, Jankovic M, Kuehni CE, Levitt G, Veres C, Aerts I, Zadravec Zaletel L, van der Pal HJH, Ronckers C, Sacerdote C, Skinner R, Jakab Z, Michel G, Terenziani M, Haddy N, Thierry-Chef I, Cardis E, Diallo I, Winter DL, Kremer LCM, Hawkins MM, de Vathaire F. Aho Glele R, et al. Among authors: van dalen ec. JAMA Oncol. 2025 Dec 1;11(12):1449-1457. doi: 10.1001/jamaoncol.2025.3863. JAMA Oncol. 2025. PMID: 41066131
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
van den Oever SR, Mulder RL, Oeffinger KC, Gietema JA, Skinner R, Constine LS, Wallace WH, Armenian S, Barnea D, Bardi E, Belle FN, Brown AL, Chemaitilly W, Crowne L, van Dalen EC, Denzer C, Ehrhardt MJ, Felicetti F, Friedman DN, Fulbright J, Glaser AW, Giwercman A, Sangstuen Haugnes H, Hayek S, Hennewig U, van den Heuvel-Eibrink MM, Haupt R, van Iersel L, Kamdar K, Lefrandt J, Levitt G, Morsellino V, Mulrooney DA, Murray RD, Neggers S, Ness KK, Neville KA, Nock NL, Otth M, Prasad PK, van Santen HM, Schindera C, Rath SR, Steinberger J, Terenziani M, Varedi M, Walwyn T, Wei C, Hudson MM, Kremer LCM, Nuver J, Tonorezos E. van den Oever SR, et al. Among authors: van dalen ec. Eur J Endocrinol. 2025 Mar 27;192(4):S27-S40. doi: 10.1093/ejendo/lvaf046. Eur J Endocrinol. 2025. PMID: 40103414
Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic review.
de Beijer IAE, Bouwman E, Mulder RL, Steensma P, Brown MC, Araújo-Soares V, Balcerek M, Bardi E, Falck Winther J, Frederiksen LE, van Gorp M, Oberti S, van Kalsbeek RJ, Kepak T, Kepakova K, Gsell H, Kienesberger A, van Litsenburg R, Mader L, Michel G, Muraca M, van den Oever SR, van der Pal HJH, Roser K, Skinner R, Stolman I, Uyttebroeck A, Kremer LCM, Loonen J, van Dalen EC, Pluijm SMF; PanCareFollowUp Consortium. de Beijer IAE, et al. Among authors: van dalen ec. Cancer Med. 2024 Jun;13(12):e7361. doi: 10.1002/cam4.7361. Cancer Med. 2024. PMID: 39291862 Free PMC article.
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.
Kouwenberg TW, van Dalen EC, Mulder RL, Armenian S, Feijen EAM, Chow EJ, Kosmidis H, Vormoor-Bürger BJ, Kiyotani C, Nathan PC, Kapusta L, Grotenhuis HB, Engels FK, Teske AJ, Tragiannidis A, Slieker MG, Ozono S, Nohria A, Sláma T, Skinner R, Hudson MM, Kremer LCM, Ehrhardt MJ, Mavinkurve-Groothuis AMC. Kouwenberg TW, et al. Among authors: van dalen ec. JACC CardioOncol. 2025 Oct;7(6):683-690. doi: 10.1016/j.jaccao.2025.05.009. Epub 2025 Jun 20. JACC CardioOncol. 2025. PMID: 40542813 Free PMC article. Review.
128 results